文献速递神经肿瘤

经蝶窦手术治疗无功能垂体大腺瘤后早期与晚期伽玛刀放射外科:多中心匹配队列研究

Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study.
PubMed 文献 · J Neurosurg · 2017-10-27

该多中心回顾性匹配队列研究纳入1987至2015年间9家国际伽玛刀研究基金会附属机构中经蝶窦手术后接受伽玛刀放射外科的无功能垂体大腺瘤患者,按术后≤6个月(早期,n=111)或>6个月(晚期,n=111)分组比较。中位影像随访68.5个月,晚期组肿瘤进展风险(p=0.013)及残余肿瘤风险(p=0.038)更高,新发内分泌病无显著差异(p=0.68)。

要点

  • 早期伽玛刀(术后≤6个月)较晚期(>6个月)与更低的影像学肿瘤进展风险相关(p=0.013)。
  • 晚期组残余肿瘤风险更高(p=0.038),中位影像随访68.5个月。
  • 新发内分泌病发生率两组无显著差异(早期30% vs 晚期27%,p=0.84)。

核心结论

  • 早期伽玛刀放射外科与次全切除的无功能垂体大腺瘤影像学进展风险较低相关,而延迟放射外科可能增加长期腺瘤进展风险。
  • 放射外科时机似乎不显著影响迟发性内分泌病的发生率。

研究设计与样本

  • 多中心回顾性研究,纳入1987至2015年间9家国际伽玛刀研究基金会附属机构中经蝶窦手术后接受伽玛刀放射外科的无功能垂体大腺瘤患者。
  • 初始收集496例患者,经匹配后222例符合研究标准,按术后≤6个月(早期,n=111)或>6个月(晚期,n=111)分组。

主要发现

  • 中位影像随访68.5个月,晚期组肿瘤进展风险高于早期组(p=0.013)。
  • 晚期组残余肿瘤风险高于早期组(p=0.038)。
  • 早期组无内分泌病患者中30%在随访期间出现新发内分泌病,晚期组为27%(p=0.84)。
  • 早期组14%患者、晚期组25%患者在初始表现后内分泌功能障碍缓解(p=0.32)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Gamma Knife radiosurgery (GKRS) is frequently used to treat residual or recurrent nonfunctioning pituitary macroadenomas. There is no consensus as to whether GKRS should be used early after surgery or if radiosurgery should be withheld until there is evidence of imaging-defined progression of tumor. Given the high incidence of adenoma progression after subtotal resection over time, the present study intended to evaluate the effect of timing of radiosurgery on outcome. METHODS This is a multicenter retrospective review of patients with nonfunctioning pituitary macroadenomas who underwent transsphenoidal surgery followed by GKRS from 1987 to 2015 at 9 institutions affiliated with the International Gamma Knife Research Foundation. Patients were matched by adenoma and radiosurgical parameters and stratified based on the interval between last resection and radiosurgery. Operative results, imaging data, and clinical outcomes were compared across groups following early (≤ 6 months after resection) or late (> 6 months after resection) radiosurgery. RESULTS After matching, 222 patients met the authors' study criteria (from an initial collection of 496 patients) and were grouped based on early (n = 111) or late (n = 111) GKRS following transsphenoidal surgery. There was a greater risk of tumor progression after GKRS (p = 0.013) and residual tumor (p = 0.038) in the late radiosurgical group over a median imaging follow-up period of 68.5 months. No significant difference in the occurrence of post-GKRS endocrinopathy was observed (p = 0.68). Thirty percent of patients without endocrinopathy in the early cohort developed new endocrinopathies during the follow-up period versus 27% in the late cohort (p = 0.84). Fourteen percent of the patients in the early group and 25% of the patients in the late group experienced the resolution of endocrine dysfunction after original presentation (p = 0.32). CONCLUSIONS In this study, early GKRS was associated with a lower risk of radiological progression of subtotally resected nonfunctioning pituitary macroadenomas compared with expectant management followed by late radiosurgery. Delaying radiosurgery may increase patient risk for long-term adenoma progression. The timing of radiosurgery does not appear to significantly affect the rate of delayed endocrinopathy.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Pomeraniec IJ, Kano H, Xu Z, et al. Early versus late Gamma Knife radiosurgery following transsphenoidal surgery for nonfunctioning pituitary macroadenomas: a multicenter matched-cohort study. J Neurosurg. 2017. PMID: 29076785. doi:10.3171/2017.5.JNS163069

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。